心脏重编程在心肌梗死修复中的研究进展
Research Progress of Cardiac Reprogramming in the Repair of Myocardial Infarction
DOI: 10.12677/ACM.2023.13102155, PDF,   
作者: 张 欣, 王晨曦:延安大学附属医院心血管内科,陕西 延安;延安大学第一临床医学院,陕西 延安
关键词: 心脏重编程心肌样细胞成纤维细胞心肌梗死Cardiac Reprogramming Cardiomyocyte-Like Cells Fibroblasts Myocardial Infarction
摘要: 人类成年心脏缺乏强大的内源性修复机制来完全恢复损伤后的心功能,因此,再生和修复受损心肌的能力是治疗心力衰竭或心肌梗死的首要任务。在体外和体内直接将成纤维细胞转化为心肌样细胞为这一问题提供了巨大的希望。此外,心肌成纤维细胞的直接重编程可规避干细胞疗法在临床应用中产生的许多问题,且为心脏再生和修复提供了有力的治疗策略。在这篇综述中,我们阐述了心脏直接重编程研究的进展,以及改善心脏重编程的效率的方法。最后,我们讨论了未来临床应用的更安全的重编程方法的发展。
Abstract: The human adult heart lacks a strong endogenous repair mechanism to completely restore the in-jured heart function. Therefore, the ability to regenerate and repair damaged myocardium is the primary task in the treatment of heart failure or myocardial infarction. Direct transformation of fi-broblasts into cardiomyocytes in vitro and in vivo provides great hope for this problem. In addition, direct reprogramming of cardiac fibroblasts can avoid many problems in clinical application of stem cell therapy, and provide a powerful therapeutic strategy for heart regeneration and repair. In this review, we describe the research progress of direct cardiac reprogramming and the methods to im-prove the efficiency of cardiac reprogramming. Finally, we discuss the development of safer repro-gramming methods for clinical application in the future.
文章引用:张欣, 王晨曦. 心脏重编程在心肌梗死修复中的研究进展[J]. 临床医学进展, 2023, 13(10): 15403-15414. https://doi.org/10.12677/ACM.2023.13102155

参考文献

[1] Khan, M.A., et al. (2020) Global Epidemiology of Ischemic Heart Disease: Results from the Global Burden of Disease Study. Cureus, 12, e9349. [Google Scholar] [CrossRef] [PubMed]
[2] Madonna, R., et al. (2016) Position Paper of the European Society of Cardiology Working Group Cellular Biology of the Heart: Cell-Based Therapies for Myocardial Repair and Regeneration in Ischemic Heart Disease and Heart Failure. European Heart Journal, 37, 1789-1798. [Google Scholar] [CrossRef] [PubMed]
[3] Bektik, E. and Fu, J.D. (2019) Ameliorating the Fibrotic Remodeling of the Heart through Direct Cardiac Reprogramming. Cells, 8, Article 679. [Google Scholar] [CrossRef] [PubMed]
[4] van Berlo, J.H. and Molkentin, J.D. (2014) An Emerging Consensus on Cardiac Regeneration. Nature Medicine, 20, 1386-1393. [Google Scholar] [CrossRef] [PubMed]
[5] Fu, J.D. and Sri-vastava, D. (2015) Direct Reprogramming of Fibroblasts into Cardiomyocytes for Cardiac Regenerative Medicine. Cir-culation Journal, 79, 245-254. [Google Scholar] [CrossRef
[6] Rao, M.S. and Malik, N. (2012) As-sessing iPSC Reprogramming Methods for Their Suitability in Translational Medicine. Journal of Cellular Biochemistry, 113, 3061-3068. [Google Scholar] [CrossRef] [PubMed]
[7] Fu, Y., et al. (2015) Direct Reprogramming of Mouse Fi-broblasts into Cardiomyocytes with Chemical Cocktails. Cell Research, 25, 1013-1024. [Google Scholar] [CrossRef] [PubMed]
[8] Lee, C.S., et al. (2017) Adenovirus-Mediated Gene Delivery: Potential Ap-plications for Gene and Cell-Based Therapies in the New Era of Personalized Medicine. Genes & Diseases, 4, 43-63. [Google Scholar] [CrossRef] [PubMed]
[9] Patel, V., et al. (2016) Direct Cardiac Cellular Reprogramming for Cardiac Regeneration. Current Treatment Options in Cardiovascular Medicine, 18, Article No. 58. [Google Scholar] [CrossRef] [PubMed]
[10] Ebert, A.D., Liang, P. and Wu, J.C. (2012) Induced Pluripotent Stem Cells as a Disease Modeling and Drug Screening Platform. Journal of Cardiovascular Pharmacology, 60, 408-416. [Google Scholar] [CrossRef
[11] Chen, T. and Vunjak-Novakovic, G. (2018) In vitro Models of Ischemia-Reperfusion Injury. Regenerative Engineering and Translational Medicine, 4, 142-153. [Google Scholar] [CrossRef] [PubMed]
[12] Wang, H.F., Yang, Y.C., Liu, J.D. and Qian, L. (2021) Direct Cell Reprogramming: Approaches, Mechanisms and Progress. Nature Reviews Molecular Cell Biology, 22, 410-424. [Google Scholar] [CrossRef] [PubMed]
[13] Tai, Y.L., Chen, K.C., Hsieh, J.T. and Shen, T.L. (2018) Exo-somes in Cancer Development and Clinical Applications. Cancer Science, 109, 2364-2374. [Google Scholar] [CrossRef] [PubMed]
[14] Querdel, E., et al. (2021) Human Engineered Heart Tissue Patches Re-muscularize the Injured Heart in a Dose-Depen- dent Manner. Circulation, 143, 1991-2006. [Google Scholar] [CrossRef
[15] Martins, A.M., Vunjak-Novakovic, G. and Reis, R.L. (2014) The Current Status of iPS Cells in Cardiac Research and Their Potential for Tissue Engineering and Regen-erative Medicine. Stem Cell Reviews and Reports, 10, 177-190. [Google Scholar] [CrossRef] [PubMed]
[16] Teshigawara, R., Cho, J., Kamed, M. and Tada, T. (2017) Mecha-nism of Human Somatic Reprogramming to iPS Cell. Laboratory Investigation, 97, 1152-1157. [Google Scholar] [CrossRef] [PubMed]
[17] Tang, B.L. (2020) Maturing iPSC-Derived Cardiomyocytes. Cells, 9, Article 213. [Google Scholar] [CrossRef] [PubMed]
[18] Pianezzi, E., et al. (2020) Role of Somatic Cell Sources in the Maturation Degree of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes. Biochimica et Biophysica Acta (BBA)—Molecular Cell Research, 1867, Article ID: 118538. [Google Scholar] [CrossRef] [PubMed]
[19] Altomare, C., et al. (2016) Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes from Cardiac Progenitor Cells: Effects of Selective Ion Channel Blockade. Europace, 18, iv67.
[20] Tohyama, S., et al. (2013) Distinct Metabolic Flow Enables Large-Scale Purification of Mouse and Human Pluripotent Stem Cell-Derived Cardiomyocytes. Cell Stem Cell, 12, 127-137. [Google Scholar] [CrossRef] [PubMed]
[21] Ieda, M., et al. (2010) Direct Reprogramming of Fibroblasts into Functional Cardiomyocytes by Defined Factors. Cell, 142, 375-386. [Google Scholar] [CrossRef] [PubMed]
[22] Wang, D., et al. (2014) MicroRNA-124 Controls the Proliferative, Migratory, and Inflammatory Phenotype of Pulmonary Vascular Fibroblasts. Circulation Research, 114, 67-78. [Google Scholar] [CrossRef
[23] Qian, L., et al. (2012) In vivo Reprogramming of Murine Cardiac Fibroblasts into Induced Cardiomyocytes. Nature, 485, 593-598. [Google Scholar] [CrossRef] [PubMed]
[24] Song, K., et al. (2012) Heart Repair by Reprogramming Non-Myocytes with Cardiac Transcription Factors. Nature, 485, 599-604. [Google Scholar] [CrossRef] [PubMed]
[25] Fu, J.D., et al. (2013) Direct Reprogramming of Human Fibroblasts toward a Cardiomyocyte-Like State. Stem Cell Reports, 1, 235-247. [Google Scholar] [CrossRef] [PubMed]
[26] Nam, Y.J., et al. (2013) Reprogramming of Human Fibroblasts toward a Cardiac Fate. Proceedings of the National Academy of Sciences of the United States of America, 110, 5588-5593. [Google Scholar] [CrossRef] [PubMed]
[27] Wada, R., et al. (2013) Induction of Human Cardiomy-ocyte-Like Cells from Fibroblasts by Defined Factors. Proceedings of the National Academy of Sciences of the United States of America, 110, 12667-12672. [Google Scholar] [CrossRef] [PubMed]
[28] Bektik, E., Dennis, A., Prasanna, P., Madabhushi, A. and Fu, J.D. (2017) Single Cell qPCR Reveals That Additional HAND2 and MicroRNA-1 Facilitate the Early Reprogramming Pro-gress of Seven-Factor-Induced Human Myocytes. PLOS ONE, 12, e0183000. [Google Scholar] [CrossRef] [PubMed]
[29] Jorstad, N.L., et al. (2017) Stimulation of Functional Neuronal Regeneration from Müller Glia in Adult Mice. Nature, 548, 103-107. [Google Scholar] [CrossRef] [PubMed]
[30] Li, H. and Chen, G. (2016) In Vivo Reprogramming for CNS Repair: Regenerating Neurons from Endogenous Glial Cells. Neuron, 91, 728-738. [Google Scholar] [CrossRef] [PubMed]
[31] Chen, Y.Q., Yang, Z.Y., Zhao, Z.A. and Shen, Z.Y. (2017) Direct Reprogramming of Fibroblasts into Cardiomyocytes. Stem Cell Research & Therapy, 8, Article No. 118. [Google Scholar] [CrossRef] [PubMed]
[32] Wang, L., et al. (2015) Stoichiometry of Gata4, Mef2c, and Tbx5 Influences the Efficiency and Quality of Induced Cardiac Myocyte Reprogramming. Circulation Research, 116, 237-244. [Google Scholar] [CrossRef
[33] Li, X.H., et al. (2015) Generation of Functional Human Cardiac Progenitor Cells by High-Efficiency Protein Transduction. Stem Cells Translational Medicine, 4, 1415-1424. [Google Scholar] [CrossRef] [PubMed]
[34] Pasumarthi, K.B. and Field, L.J. (2002) Cardiomyocyte Cell Cycle Regulation. Circulation Research, 90, 1044-1054. [Google Scholar] [CrossRef
[35] Barreto, S., Hamel, L., Schiatti, T., Yang, Y. and George, V. (2019) Cardiac Progenitor Cells from Stem Cells: Learning from Genetics and Biomaterials. Cells, 8, Article 1536. [Google Scholar] [CrossRef] [PubMed]
[36] Li, P., Kaslan, M., Lee, S.H., Yao, J. and Gao, Z.Q. (2017) Pro-gress in Exosome Isolation Techniques. Theranostics, 7, 789-804. [Google Scholar] [CrossRef] [PubMed]
[37] Sandmaier, S.E. and Telugu, B.P. (2015) MicroRNA-Mediated Repro-gramming of Somatic Cells into Induced Pluripotent Stem Cells. In: Verma, P. and Sumer, H., Eds., Cell Reprogram-ming, Humana Press, New York, 29-36. [Google Scholar] [CrossRef] [PubMed]
[38] Elmén, J., et al. (2008) LNA-Mediated MicroRNA Silencing in Non-Human Primates. Nature, 452, 896-899. [Google Scholar] [CrossRef] [PubMed]
[39] Sridharan, R. and Plath, K. (2011) Small RNAs Loom Large during Re-programming. Cell Stem Cell, 8, 599-601. [Google Scholar] [CrossRef] [PubMed]
[40] Jayawardena, T.M., et al. (2012) MicroRNA-Mediated in Vitro and in Vivo Direct Reprogramming of Cardiac Fibroblasts to Cardiomyocytes. Circulation Research, 110, 1465-1473. [Google Scholar] [CrossRef
[41] Maitra, M., et al. (2009) Interaction of Gata4 and Gata6 with Tbx5 Is Critical for Normal Cardiac Development. Developmental Biology, 326, 368-377. [Google Scholar] [CrossRef] [PubMed]
[42] Oka, T., et al. (2006) Cardiac-Specific Deletion of Gata4 Reveals Its Requirement for Hypertrophy, Compensation, and Myocyte Viability. Circulation Research, 98, 837-845. [Google Scholar] [CrossRef
[43] Lin, Q., Schwarz, J., Bucana, C. and Olson, E.N. (1997) Control of Mouse Cardiac Morphogenesis and Myogenesis by Transcription Factor MEF2C. Science, 276, 1404-1407. [Google Scholar] [CrossRef] [PubMed]
[44] Protze, S., et al. (2012) A New Approach to Tran-scription Factor Screening for Reprogramming of Fibroblasts to Cardiomyocyte-Like Cells. Journal of Molecular and Cellular Cardiology, 53, 323-332. [Google Scholar] [CrossRef] [PubMed]
[45] Mathison, M., et al. (2017) Cardiac Reprogramming Factor Ga-ta4 Reduces Postinfarct Cardiac Fibrosis through Direct Repression of the Profibrotic Mediator Snail. The Journal of Thoracic and Cardiovascular Surgery, 154, 1601- 1610.E3. [Google Scholar] [CrossRef] [PubMed]
[46] Addis, R.C., et al. (2013) Optimization of Direct Fibroblast Re-programming to Cardiomyocytes Using Calcium Activity as a Functional Measure of Success. Journal of Molecular and Cellular Cardiology, 60, 97-106. [Google Scholar] [CrossRef] [PubMed]
[47] Hirai, H., Katoku-Kikyo, N., Karian, P., Firpo, M. and Kikyo, N. (2012) Efficient iPS Cell Production with the MyoD Transactivation Domain in Serum-Free Culture. PLOS ONE, 7, e34149. [Google Scholar] [CrossRef] [PubMed]
[48] Hirai, H., Katoku-Kikyo, N., Keirstead, S.A. and Kikyo, N. (2013) Accelerated Direct Reprogramming of Fibroblasts into Cardiomyocyte-Like Cells with the MyoD Transactivation Domain. Cardiovascular Research, 100, 105-113. [Google Scholar] [CrossRef] [PubMed]
[49] Zhou, H., Dickson, M.E., Kim, M.S., Bassel-Duby, R. and Olson, E.N. (2015) Akt1/Protein Kinase B Enhances Transcriptional Reprogramming of Fibroblasts to Functional Cardiomyocytes. Proceedings of the National Academy of Sciences of the United States of America, 112, 11864-11869. [Google Scholar] [CrossRef] [PubMed]
[50] Abad, M., et al. (2017) Notch Inhibition Enhances Cardiac Repro-gramming by Increasing MEF2C Transcriptional Activity. Stem Cell Reports, 8, 548-560. [Google Scholar] [CrossRef] [PubMed]
[51] Collesi, C., Zentilin, L., Sinagra, G. and Giacca, M. (2008) Notch1 Signaling Stimulates Proliferation of Immature Cardiomyocytes. Journal of Cell Biology, 183, 117-128. [Google Scholar] [CrossRef] [PubMed]
[52] Liu, Y., et al. (2014) Timely Inhibition of Notch Signaling by DAPT Promotes Cardiac Differentiation of Murine Pluripotent Stem Cells. PLOS ONE, 9, e109588. [Google Scholar] [CrossRef] [PubMed]
[53] Zhou, Y., et al. (2016) Bmi1 Is a Key Epigenetic Barrier to Di-rect Cardiac Reprogramming. Cell Stem Cell, 18, 382- 395. [Google Scholar] [CrossRef] [PubMed]
[54] Guo, Y., et al. (2019) Chemical Suppression of Specific C-C Chemokine Signaling Pathways Enhances Cardiac Reprogram-ming. Journal of Biological Chemistry, 294, 9134-9146. [Google Scholar] [CrossRef
[55] Singh, V.P., et al. (2021) Hippo Pathway Effector Tead1 Induces Cardiac Fibroblast to Cardiomyocyte Reprogramming. Jour-nal of the American Heart Association, 10, e022659. [Google Scholar] [CrossRef
[56] Bock-Marquette, I., Saxena, A., White, M.D., DiMaio, J.M. and Srivastava, D. (2004) Thymosin β4 Activates Integrin-Linked Kinase and Promotes Cardiac Cell Migration, Survival and Cardiac Repair. Nature, 432, 466-472. [Google Scholar] [CrossRef] [PubMed]
[57] Vincentz, J.W., Toolan, K.P., Zhang, W.J. and Firulli, A.B. (2017) Hand Factor Ablation Causes Defective Left Ventricular Chamber Development and Compromised Adult Cardiac Function. PLOS GENETICS, 13, e1006922. [Google Scholar] [CrossRef] [PubMed]
[58] VanDusen, N.J., et al. (2014) Hand2 Is an Essential Regulator for Two Notch-Dependent Functions within the Embryonic Endocardium. Cell Reports, 9, 2071-2083. [Google Scholar] [CrossRef] [PubMed]
[59] Inagawa, K., et al. (2012) Induction of Cardiomyocyte-Like Cells in Infarct Hearts by Gene Transfer of Gata4, Mef2c, and Tbx5. Circulation Research, 111, 1147-1156. [Google Scholar] [CrossRef
[60] Mathison, M., et al. (2014) “Triplet” Polycistronic Vec-tors Encoding Gata4, Mef2c, and Tbx5 Enhances Postinfarct Ventricular Functional Improvement Compared with Singlet Vectors. The Journal of Thoracic and Cardiovascular Surgery, 148, 1656-1664.E2. [Google Scholar] [CrossRef] [PubMed]
[61] Islas, J.F., et al. (2012) Transcription Factors ETS2 and MESP1 Transdifferentiate Human Dermal Fibroblasts into Cardiac Progenitors. Proceedings of the National Academy of Sciences of the United States of America, 109, 13016- 13021. [Google Scholar] [CrossRef] [PubMed]
[62] Wang, T., et al. (2015) Estrogen-Related Receptor α (ERRα) and ERRγ Are Essential Coordinators of Cardiac Metabolism and Function. Molecular and Cellular Biology, 35, 1281-1298. [Google Scholar] [CrossRef
[63] Zhang, W., et al. (2014) Novel Missense Variants of ZFPM2/FOG2 Identified in Conotruncal Heart Defect Patients Do Not Impair Inter-action with GATA4. PLOS ONE, 9, e102379. [Google Scholar] [CrossRef] [PubMed]
[64] Muraoka, N., et al. (2014) MiR-133 Promotes Cardiac Reprogramming by Directly Repressing Snai1 and Silencing Fibroblast Signa-tures. The EMBO Journal, 33, 1565-1581. [Google Scholar] [CrossRef] [PubMed]
[65] Christoforou, N., et al. (2017) Core Transcription Factors, MicroRNAs, and Small Molecules Drive Transdifferentiation of Human Fibroblasts towards the Cardiac Cell Lineage. Scientific Reports, 7, Article No. 40285. [Google Scholar] [CrossRef] [PubMed]
[66] Gassmann, M., et al. (1995) Aberrant Neural and Cardiac Development in Mice Lacking the ErbB4 Neuregulin Receptor. Nature, 378, 390-394. [Google Scholar] [CrossRef] [PubMed]
[67] Pomeroy, J.E., Helfer, A. and Bursac, N. (2020) Biomaterializing the Prom-ise of Cardiac Tissue Engineering. Biotechnology Advances, 42, Article ID: 107353. [Google Scholar] [CrossRef] [PubMed]
[68] Sadahiro, T., et al. (2018) Tbx6 Induces Nascent Mesoderm from Pluripotent Stem Cells and Temporally Controls Cardiac versus Somite Lineage Diversification. Cell Stem Cell, 23, 382-395.E5. [Google Scholar] [CrossRef] [PubMed]
[69] Christoforou, N., et al. (2013) Transcription Factors MYOCD, SRF, Mesp1 and SMARCD3 Enhance the Cardio-Indu- cing Effect of GATA4, TBX5, and MEF2C during Direct Cellular Reprogramming. PLOS ONE, 8, e63577. [Google Scholar] [CrossRef] [PubMed]
[70] Zhao, H., et al. (2021) Sall4 and Myocd Empower Direct Car-diac Reprogramming from Adult Cardiac Fibroblasts after Injury. Frontiers in Cell and Developmental Biology, 9, Article 608367. [Google Scholar] [CrossRef] [PubMed]
[71] Sia, J., Yu, P.Z., Srivastava, D. and Li, S. (2016) Effect of Biophysical Cues on Reprogramming to Cardiomyocytes. Biomaterials, 103, 1-11. [Google Scholar] [CrossRef] [PubMed]
[72] Kurotsu, S., et al. (2020) Soft Matrix Promotes Cardiac Reprogramming via Inhibition of YAP/TAZ and Suppression of Fibroblast Signatures. Stem Cell Reports, 15, 612-628. [Google Scholar] [CrossRef] [PubMed]
[73] Li, Y., et al. (2016) Tissue-Engineered 3-Dimensional (3D) Mi-croenvironment Enhances the Direct Reprogramming of Fibroblasts into Cardiomyocytes by MicroRNAs. Scientific Re-ports, 6, Article No. 38815. [Google Scholar] [CrossRef] [PubMed]
[74] Bunney, P.E., Zink, A.N., Holm, A.A., Billington, C.J. and Kotz, C.M. (2017) Orexin Activation Counteracts Decreases in Nonexercise Activity Thermogenesis (NEAT) Caused by High-Fat Diet. Physiology & Behavior, 176, 139-148. [Google Scholar] [CrossRef] [PubMed]
[75] Sauls, K., et al. (2018) Initiating Events in Direct Cardiomyo-cyte Reprogramming. Cell Reports, 22, 1913-1922. [Google Scholar] [CrossRef] [PubMed]
[76] Smith, A.W., et al. (2013) Direct Reprogramming of Mouse Fi-broblasts to Cardiomyocyte-Like Cells Using Yamanaka Factors on Engineered Poly (Ethylene Glycol) (PEG) Hydro-gels. Biomaterials, 34, 6559-6571. [Google Scholar] [CrossRef] [PubMed]
[77] Liu, Z., et al. (2016) Re-Patterning of H3K27me3, H3K4me3 and DNA Methylation during Fibroblast Conversion into Induced Cardiomyocytes. Stem Cell Research, 16, 507-518. [Google Scholar] [CrossRef] [PubMed]
[78] Liu, Z., et al. (2017) Single-Cell Transcriptomics Recon-structs Fate Conversion from Fibroblast to Cardiomyocyte. Nature, 551, 100-104. [Google Scholar] [CrossRef] [PubMed]
[79] Plotkin, J.B. (2010) Transcriptional Regulation Is Only Half the Story. Molecular Systems Biology, 6, 406. [Google Scholar] [CrossRef] [PubMed]
[80] Liu, Y., et al. (2018) CRISPR Activation Screens Systematically Identify Factors That Drive Neuronal Fate and Reprogramming. Cell Stem Cell, 23, 758-771.E8. [Google Scholar] [CrossRef] [PubMed]
[81] Weltner, J., et al. (2018) Human Pluripotent Reprogramming with CRISPR Activators. Nature Communications, 9, Article No. 2643. [Google Scholar] [CrossRef] [PubMed]
[82] Farbehi, N., et al. (2019) Single-Cell Expression Profiling Re-veals Dynamic Flux of Cardiac Stromal, Vascular and Immune Cells in Health and Injury. eLife, 8, e43882. [Google Scholar] [CrossRef
[83] Skelly, D.A., et al. (2018) Single-Cell Transcriptional Profiling Reveals Cellular Diversity and Intercommunication in the Mouse Heart. Cell Reports, 22, 600-610. [Google Scholar] [CrossRef] [PubMed]